Frontier Capital Management CO LLC Amarin Corp Plcuk Transaction History

Frontier Capital Management CO LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 19, 2021	SELL	$4.04 - $5.31 $1.48 Million - $1.94 Million	-366,104 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$3.64 - $7.76 $700,397 - $1.49 Million	-192,417 Reduced 34.45%	366,104 $1.54 Million
Q2 2020 Jul 17, 2020	BUY	$4.78 - $8.26 $1.86 Million - $3.21 Million	388,417 Added 228.34%	558,521 $3.87 Million
Q1 2020 Apr 16, 2020	BUY	$4.0 - $21.53 $155,148 - $835,084	38,787 Added 29.54%	170,104 $680,000
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $4.11 Million - $7.11 Million	-294,969 Reduced 69.2%	131,317 $2.82 Million

Q3 2019 Nov 14, 2019	SELL	$13.89 - $23.16 $8.36 Million - $13.9 Million	-602,188 Reduced 58.55%	426,286 $6.46 Million
Q2 2019 Aug 14, 2019	BUY	$16.27 - $20.51 $109,708 - $138,298	6,743 Added 0.66%	1,028,474 $19.9 Million
Q1 2019 May 07, 2019	BUY	$12.61 - $22.33 $10.3 Million - $18.2 Million	815,616 Added 395.71%	1,021,731 $21.2 Million
Q4 2018 Jan 25, 2019	SELL	$12.41 - $22.98 $2.03 Million - $3.76 Million	-163,732 Reduced 44.27%	206,115 $2.81 Million
Q3 2018 Oct 30, 2018	BUY	$2.45 - $16.27 $906,125 - $6.02 Million	369,847 New	369,847 $6.02 Million

184

87.9M

528K

219K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $278M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Capital Management CO LLC with notifications on news.